Search results for Generic Semaglutide

Generic semaglutide to hit Canadian pharmacies this week at lower cost

Health Canada approved both Dr. Reddy's and Apotex's generic semaglutide — the active ingredient in brand-name Ozempic and Wegovy — about three weeks ago.

Canada approves 2nd generic version of semaglutide

Canada is the first G7 country to authorize generic semaglutide. There are now seven other submissions currently under review for generic semaglutide by different companies.

Health Canada approves country’s 1st generic version of Ozempic

The injectable semaglutide medication is manufactured by Dr. Reddy's Laboratories in India and is approved for the once-weekly treatment of Type 2 diabetes in adults.

559 REAL WORLD GI SAFETY COMPARISON OF SEMAGLUTIDE AND TIRZEPATIDE: A PHARMACOVIGILANCE STUDY

With Canada approving 1st generic semaglutide, how will costs compare?

Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.

Dr Reddy’s launches its generic Semaglutide injection in Canada

The Hyderabad-based company received Health Canada approval for Semaglutide Injection on April 28, 2026, making Canada the first G7 country to grant market authorisation

Dr Reddy's Launches Oral Semaglutide Biosimilar Obeda In India

Oral semaglutide, a glucagon-Like Peptide-1 receptor agonist (GLP-1 RA), is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes...

Oral Semaglutide Lowers Cardiometabolic Risks in Obesity

In a groundbreaking advancement in the management of cardiometabolic risk factors among overweight and obese populations, a new comprehensive study published in BMC Pharmacology an...

Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalen...

TORONTO, May 1, 2026 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), Canada's largest Canadian‑based global health company, today announced that Health Canada has approved...

Dr. Reddy’s Laboratories Launches its Generic Semaglutide Injection in Canada

The launch follows Dr. Reddy’s receipt of the Notice of Compliance (NOC) from Health Canada on April 28th, 2026, marking the company’s readiness to serve Canadian patients Dr. Redd...

Health Canada approves 2nd generic version of Ozempic — and it’s Canadian

TORONTO — Health Canada has approved the second generic version of brand-name Ozempic, this one manufactured by Canadian company Apotex. The authorization for the medication called...

Health Canada approves 1st generic version of Ozempic in the country

TORONTO — Health Canada has approved the first generic version of brand-name Ozempic. The department says Canada is the first G7 country to authorize generic semaglutide. The injec...

Semaglutide cuts BMI by 19% in treatment-resistant young adults with severe obesity, finds trial

A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are t...

Orbicular gets USFDA’s tentative nod for generic Semaglutide Injection in partnership with Apotex

The product will be marketed and commercialised in the United States by Apotex Corp., the ANDA applicant

FDA Proposal Would Leave Semaglutide, Tirzepatide, and Liraglutide Off 503B Bulks List

On April 30, 2026, the U.S. Food and Drug Administration (FDA) announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulk Drug Substances List (“5...

Ozempic delivers major weight loss in adults over 65, study finds

A major new analysis suggests semaglutide (Ozempic, Wegovy) works remarkably well in adults over 65, helping many lose substantial amounts of weight while improving heart and metab...

Semaglutide helps patients who gain weight after bariatric surgery

New UCL research supports use of the weight loss drug semaglutide for patients who do not get enough benefit from bariatric surgery.

Canada approves second generic version of Ozempic

Semaglutide Shows Surprising Mental Health Benefits in Massive 100,000-Person Study

A large-scale study suggests that GLP-1 drugs could have unexpected mental health benefits, including lower risks of depression, anxiety, and substance use. GLP-1 medications like...

Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

India is the first market where Novo Nordisk faces generic competition for semaglutide — the active ingredient in Ozempic and Wegovy.

New Nature Communications Publication Highlights Efsubaglutide Alfa's Effects on Glycaemia and β-Cell Function

HONG KONG, May 12, 2026 /PRNewswire/ -- A major new clinical study, SUPER 2, has been published in Nature Communications, reporting that Efsubaglutide Alfa, a long-acting GLP-1 rec...

Novo Nordisk will slash Ozempic price for some, ‘aligning’ with generics

Ozempic and Wegovy, both produced by Novo Nordisk, currently cost hundreds of dollars a month, depending on the dosage dispensed, in some cases more than $450.

Study Aims to Break GLP-1 Weight-Loss Plateaus

The weight-loss effects of semaglutide depend on boosting a signaling molecule called cAMP within appetite-regulating neurons in the area postrema.

GLP-1 Weight Loss Linked To Dramatically Lower Risk of Sleep Apnea, Kidney Disease and More

New research indicates that maintaining meaningful weight loss after starting GLP-1-based therapies could play an important role in reducing the risk of multiple obesity-related di...